omega-aminoenantic acid has been researched along with lysine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castellino, FJ; De Serrano, VS | 2 |
| Ishii, H; Murayama, N; Sasaki, T; Sugimoto, K; Takada, K; Yamamoto, K; Yamazaki, H; Yoshimoto, N | 1 |
3 other study(ies) available for omega-aminoenantic acid and lysine
| Article | Year |
|---|---|
The cationic locus on the recombinant kringle 2 domain of tissue-type plasminogen activator that stabilizes its interaction with omega-amino acids.
Topics: Amino Acid Sequence; Amino Acids; Aminocaproic Acid; Base Sequence; Binding Sites; Cations; DNA; Enzyme Stability; Escherichia coli; Lysine; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Peptide Fragments; Plasmids; Recombinant Proteins; Tissue Plasminogen Activator; Tranexamic Acid | 1992 |
Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with omega-amino acid ligands.
Topics: Amino Acid Sequence; Amino Acids; Aminocaproic Acid; Anions; Base Sequence; Binding Sites; Escherichia coli; Lysine; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Peptide Fragments; Recombinant Proteins; Thermodynamics; Tissue Plasminogen Activator; Tranexamic Acid; X-Ray Diffraction | 1993 |
Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis.
Topics: Administration, Intravenous; Administration, Oral; Amino Acids; Animals; Carboxypeptidase B2; Fibrinolysis; Fibrinolytic Agents; Humans; Lysine; Male; Rats; Sulfur Compounds; Thromboplastin; Thrombosis | 2012 |